(Q30891346)

27 June 2017

title

Long-term tolerability of lamotrigine: data from a 6-year continuation study (English)

1 reference

27 June 2017

1 reference

Edward Faught

1

1 reference

27 June 2017

Fumisuke U Matsuo

2

1 reference

27 June 2017

Steven Schachter

3

1 reference

27 June 2017

John Messenheimer

4

1 reference

27 June 2017

Gilda P Womble

5

1 reference

27 June 2017

language of work or name

1 reference

1 February 2004

1 reference

27 June 2017

1 reference

27 June 2017

volume

5

1 reference

27 June 2017

issue

1

1 reference

27 June 2017

page(s)

31-36

1 reference

Controlled trial of lamotrigine (Lamictal) for refractory partial seizures

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

An active-control trial of lamotrigine monotherapy for partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Lamotrigine in typical absence epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Safety review of adult clinical trial experience with lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Stable weight during lamotrigine therapy: a review of 32 studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Lamotrigine-associated rash: risk/benefit considerations in adults and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Safety of long-term lamotrigine in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

Rash in adult and pediatric patients treated with lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.10.011

10.1016/J.YEBEH.2003.10.011

7 January 2021

Identifiers

DOI

1 reference

27 June 2017

1 reference